Submission Details
| 510(k) Number | K951441 FDA.gov |
| FDA Decision | Cleared SESE |
| Date Received | March 29, 1995 |
| Decision Date | June 01, 1995 |
| Days to Decision | 64 days |
| Submission Type | Traditional |
| Review Panel | Toxicology (TX) |
| Summary | Summary PDF |
K951441 is an FDA 510(k) clearance for the DUPONT ACA DIGOXIN (DGN A) METHOD, a Enzyme Immunoassay, Digoxin (Class II — Special Controls, product code KXT), submitted by E.I. Dupont DE Nemours & Co., Inc. (Wilmington, US). The FDA issued a Cleared decision on June 1, 1995, 64 days after receiving the submission on March 29, 1995. This device falls under the Toxicology review panel. Regulated under 21 CFR 862.3320.
| 510(k) Number | K951441 FDA.gov |
| FDA Decision | Cleared SESE |
| Date Received | March 29, 1995 |
| Decision Date | June 01, 1995 |
| Days to Decision | 64 days |
| Submission Type | Traditional |
| Review Panel | Toxicology (TX) |
| Summary | Summary PDF |
| Product Code | KXT — Enzyme Immunoassay, Digoxin |
| Device Class | Class II — Special Controls |
| CFR Regulation | 21 CFR 862.3320 |